Cytek Biosciences Inc. is a biotechnology company that specializes in advancing the capabilities of flow cytometry technologies. Its primary function is to develop and deliver transformative, cost-effective products for researchers and clinicians in the life sciences sector. The company is renowned for its full spectrum flow cytometry systems, which allow users to conduct high-parameter cell analysis with higher accuracy and efficiency compared to traditional methods. This technology has significant implications in numerous fields, including immunology, oncology, and stem cell research, thereby supporting efforts in drug discovery, clinical trials, and personalized medicine. Cytek Biosciences Inc.'s offerings play a crucial role in enabling scientific discoveries and advancing public health initiatives. As a prominent player in the biotechnology market, Cytek contributes to pushing the boundaries of what's possible in cellular analysis, fostering breakthroughs that can lead to new therapeutic strategies and medical treatments.